益佰制药

- 600594

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
益佰制药(600594) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入57,264.61282,056.10213,683.43147,970.1468,379.79
营业收入57,264.61282,056.10213,683.43147,970.1468,379.79
二、营业总成本63,520.37262,142.58193,020.82131,699.8362,269.10
营业成本22,576.3386,109.6362,780.5842,561.5221,875.75
营业税金及附加949.954,265.873,394.352,313.561,220.34
销售费用29,218.54123,844.0693,675.6465,098.5229,651.09
管理费用7,689.0935,147.8124,676.5716,630.987,189.37
财务费用806.881,560.481,108.40258.2686.35
研发费用2,279.5811,214.737,385.284,836.992,246.20
资产减值损失----------
公允价值变动收益----------
投资收益5.872.8711.312.39-11.67
其中:对联营企业和合营企业的投资收益6.13-34.21-25.77-20.31-12.13
汇兑收益----------
三、营业利润-6,773.1213,735.8019,930.7915,574.365,447.89
加:营业外收入2.94479.31120.1819.601.72
减:营业外支出206.40983.04560.22229.73177.48
其中:非流动资产处置损失----------
四、利润总额-6,976.5713,232.0719,490.7515,364.235,272.13
减:所得税费用164.614,096.363,340.763,191.391,121.33
五、净利润-7,141.189,135.7116,149.9912,172.844,150.80
归属于母公司所有者的净利润-6,845.4810,339.9016,987.0012,790.604,399.99
少数股东损益-295.70-1,204.19-837.01-617.77-249.20
六、每股收益
基本每股收益(元/股)-0.08600.13100.21500.16200.0560
稀释每股收益(元/股)-0.08600.13100.21500.16200.0560
七、其他综合收益3.95-34.36-34.36---14.56
八、综合收益总额-7,137.229,101.3516,115.6312,172.844,136.23
归属于母公司所有者的综合收益总额-6,841.5310,305.5416,952.6312,790.604,385.43
归属于少数股东的综合收益总额-295.70-1,204.19-837.01-617.77-249.20
下载全部历史数据到excel中 返回页顶